LCI699 structure, CAS 928134-65-0

LCI699

CAS Number928134-65-0

Synonymsosilodrostat; 4-(quinolin-3-ylmethyl-amino)-benzenesulfonamide; Novartis LCI699; (R)-4-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluorobenzonitrile; UNII-5YL4IQ1078; 4-[(5R)-6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile; 3-<N-(4'-Amidosulfonylphenyl)aminomethyl>quinoline; 4-((R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluoro-benzonitrile

Molecular FormulaC13H10FN3

Molecular Weight227.24

Purity

Density1.3±0.1 g/cm3

Boiling Point433.8±45.0 °C at 760 mmHg

Melting Point

Flash Point

Appearancepowder

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1190043 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 928134-65-0 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number928134-65-0
Catalog No.2A-1190043
Chinese NameOsilodrostat (LCI699)
Synonymsosilodrostat; 4-(quinolin-3-ylmethyl-amino)-benzenesulfonamide; Novartis LCI699; (R)-4-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluorobenzonitrile; UNII-5YL4IQ1078; 4-[(5R)-6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile; 3-<N-(4'-Amidosulfonylphenyl)aminomethyl>quinoline; 4-((R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluoro-benzonitrile
Molecular FormulaC13H10FN3
Molecular Weight227.24
Density1.3±0.1 g/cm3
Boiling Point433.8±45.0 °C at 760 mmHg
Appearancepowder
Storage Condition-20℃
ApplicationOsilodrostat (LCI699) is a potent inhibitor of human 11β-hydroxylase and aldosterone synthase, with IC50 values ​​of 2.5 and 0.7nM respectively.
PubChem ID85095657
MDL NumberC13H10FN3
SMILESN#Cc1ccc(C2CCc3cncn32)c(F)c1
InChIInChI=1S/C13H10FN3/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13/h1,3,5,7-8,13H,2,4H2/t13-/m1/s1
InChI KeyUSUZGMWDZDXMDG-CYBMUJFWSA-N
Transport InfoProduct name: Osilodrostat (LCI699)
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA